BioNTech's stock (BNTX) tumbled 7.70% in the last session, or 12.46 points, settling at 149.27 points, with trading volumes surpassing 1.1 million shares, above 10-day averages of 800 thousand shares, amid the dominance of the downward correctional short-term trend, with negative pressure from the 50-day SMA.
Therefore we expect more losses for the stock, targeting the pivotal support of 135.13, provided the resistance of 189.00 holds on.
Trade US Stocks with 1:50 leverage
Expected trend for today: Bearish
Facebook's stock (META) skidded in the last session after changing its icon from FB to META, with Bloomberg reporting the company stopped developing a smart watch to work on other wrist devices, with the stock tumbling 6.43%, or 12.64 points, settling at 184.00, with trading volumes at 23.5 million shares, below 10-day averages of 25.4 million shares.
The stock is facing resistance from the 50-day SMA, amid the dominance of the main downward trend in the short term, doubling pressures, amid negative signals from the RSI after reaching overbought levels.
Therefore we expect more losses for the stock, targeting the pivotal support of 169.00, provided the resistance of 213.15 holds on.
Trade US Stocks with 1:50 leverage
Expected trend for today: Bearish
NXP Semiconductors' stock (NXPI) rose in the intraday levels, becoming one of the best performers in the market, and marking a profit of 4.04% in the last session, or 7.15 points, and settling at 184.22, with trading volumes surpassing 10.1 million shares, above 10-day averages of 3.6 million shares after reports that Samsung might acquire the company.
Technically, the stock is receiving support after leaning on the 50-day SMA, while boosted by a positive pattern that formed in the short term, the Falling Wedge, with positive signals from the RSI after reaching oversold levels compared to the stock's movements.
Therefore we expect more gains for the stock, targeting the first resistance at 211.83, provided the support of 175.55 holds on.
Trade US Stocks with 1:50 leverage
Expected trend for today: Bullish
Moderna's stock (MRNA) skidded 9.76% in the last session, or 14.49 points, settling at 134.04, with trading volumes surpassing 7.5 million shares, above 10-day averages of 5.5 million shares, amid worries the FDA will delay approvals for the Covid 19 booster.
The stock received pressure after touching the resistance of the 50-day SMA, amid the dominance of the downward correctional short-term trend, while the RSI reached overbought levels.
Therefore we expect more losses for the stock, targeting the pivotal support of 122.00, provided the resistance of 155.46 holds on.
Trade US Stocks with 1:50 leverage
Expected trend for today: Bearish